MGIM
CPRX

M&G Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

M&G Investment Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-228,278
Closed -$1.6K – 428
2022
Q2 		$1.6K Buy
228,278
+11,514
+5% +$84.5K 0.01% 296
2022
Q1 		$1.73K Buy
+216,764
New +$1.53M ﹤0.01% 301

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&G Investment Management's CPRX Position: Q3 2022 in Review

M&G Investment Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2022, closing a stake of 228,278 shares — an estimated $1.6K sold.

M&G Investment Management first reported a position in CPRX in Q1 2022 and held it in 2 quarters. The position peaked at $1.73K in Q1 2022. 229 funds tracked by Wall St. Rank hold CPRX as of Q3 2022.

  • M&G Investment Management reported no remaining Catalyst Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • M&G Investment Management sold 228,278 Catalyst Pharmaceutical shares in Q3 2022, an estimated $1.6K.
  • M&G Investment Management first reported a position in Catalyst Pharmaceutical in Q1 2022 and held it in 2 quarters.
  • M&G Investment Management's Catalyst Pharmaceutical position peaked at $1.73K in Q1 2022.
  • 229 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2022.

Based on M&G Investment Management's 13F filing for Q3 2022, filed 1 Nov 2022.